Figure 1.
Analysis of multi-omics data showed that PKMYT1 was over-expressed in BC and could serve as an independent prognostic marker. (A, B) The PKMYT1 mRNA expression levels in BC microarray data and paired TCGA-BRCA cohort; (C) The mRNA expression levels of PKMYT1 in local cohort sample; (D) DNA methylation levels of PKMYT1 between BC and normal tissues were analyzed using HM450 chip sequencing data of TCGA-BRCA cohort; (E, F) The correlation between PKMYT1 mRNA expression level and PKMYT1 copy number variation or methylation level in TCGA-BRCA cohort; (G–J) Kaplan-Meier analysis for RFS and OS of BC patients in the KM-plotter cohort and METABRIC cohort; (K) Univariate and multivariate Cox regression analysis for OS of BC patients in METABRIC cohort.